Bristol Myers Squibb Co. (BMY)
62.19
-0.13
(-0.21%)
USD |
NYSE |
Nov 13, 10:17
Bristol Myers Squibb Market Cap : 127.12B for Nov. 13, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 127.38B |
| November 11, 2026 | 128.59B |
| November 10, 2026 | 128.36B |
| November 09, 2026 | 127.01B |
| November 06, 2026 | 127.01B |
| November 05, 2026 | 129.04B |
| November 04, 2026 | 131.20B |
| November 03, 2026 | 126.14B |
| November 02, 2026 | 128.81B |
| October 30, 2026 | 127.71B |
| October 29, 2026 | 125.48B |
| October 28, 2026 | 123.81B |
| October 27, 2026 | 125.81B |
| October 26, 2026 | 125.87B |
| October 23, 2026 | 125.60B |
| October 22, 2026 | 128.71B |
| October 21, 2026 | 124.87B |
| October 20, 2026 | 126.01B |
| October 19, 2026 | 120.19B |
| October 16, 2026 | 122.07B |
| October 15, 2026 | 123.74B |
| October 14, 2026 | 121.11B |
| October 13, 2026 | 115.78B |
| October 12, 2026 | 117.64B |
| October 09, 2026 | 120.78B |
| Date | Value |
|---|---|
| October 08, 2026 | 121.72B |
| October 07, 2026 | 121.97B |
| October 06, 2026 | 121.74B |
| October 05, 2026 | 120.15B |
| October 02, 2026 | 124.93B |
| October 01, 2026 | 125.56B |
| September 30, 2026 | 127.48B |
| September 29, 2026 | 128.42B |
| September 28, 2026 | 130.51B |
| September 25, 2026 | 128.42B |
| September 24, 2026 | 125.64B |
| September 23, 2026 | 124.93B |
| September 22, 2026 | 127.18B |
| September 21, 2026 | 127.93B |
| September 18, 2026 | 128.83B |
| September 17, 2026 | 128.38B |
| September 16, 2026 | 129.93B |
| September 15, 2026 | 130.20B |
| September 14, 2026 | 130.96B |
| September 11, 2026 | 130.02B |
| September 10, 2026 | 130.24B |
| September 09, 2026 | 131.59B |
| September 08, 2026 | 132.16B |
| September 04, 2026 | 136.51B |
| September 03, 2026 | 139.11B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Johnson & Johnson | 686.82B |
| Eli Lilly & Co. | 1.339T |
| Merck & Co., Inc. | 359.63B |
| Pfizer Inc. | 163.99B |
| AstraZeneca PLC | 573.59B |
Market Cap Related Metrics
| PE Ratio | 13.78 |
| PS Ratio | 2.544 |
| PEG Ratio | 0.2631 |
| Price to Book Value | 5.431 |
| Price to Free Cash Flow | 13.71 |
| Price | 62.19 |
| Earnings Yield | 7.26% |
| PEGY Ratio | 0.2442 |
| Operating PE Ratio | 7.725 |
| Normalized PE Ratio | 9.741 |